Bearish
Shareholder Alert: Ademi LLP investigates whether Rallybio Corporation is obtaining a Fair Price for Public Shareholders
Ademi LLP is investigating Rallybio (Nasdaq: RLY) regarding its recently announced transaction with Avenzo Therapeutics, citing potential breaches of ...